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A single pulse of agrin triggers a pathway that acts to cluster
acetylcholine receptors
Abstract
Agrin triggers signaling mechanisms of high temporal and spatial specificity to achieve
phosphorylation, clustering, and stabilization of postsynaptic acetylcholine receptors (AChRs). Agrin
transiently activates the kinase MuSK; MuSK activation has largely vanished when AChR clusters
appear. Thus, a tyrosine kinase cascade acts downstream from MuSK, as illustrated by the agrin-evoked
long-lasting activation of Src family kinases (SFKs) and their requirement for AChR cluster
stabilization. We have investigated this cascade and report that pharmacological inhibition of SFKs
reduces early but not later agrin-induced phosphorylation of MuSK and AChRs, while inhibition of Abl
kinases reduces late phosphorylation. Interestingly, SFK inhibition applied selectively during
agrin-induced AChR cluster formation caused rapid cluster dispersal later upon agrin withdrawal. We
also report that a single 5-min agrin pulse, followed by extensive washing, triggered long-lasting MuSK
and AChR phosphorylation and efficient AChR clustering. Following the pulse, MuSK phosphorylation
increased and, beyond a certain level, caused maximal clustering. These data reveal novel temporal
aspects of tyrosine kinase action in agrin signaling. First, during AChR cluster formation, SFKs initiate
early phosphorylation and an AChR stabilization program that acts much later. Second, a kinase
mechanism rapidly activated by agrin acts thereafter autonomously in agrin's absence to further increase
MuSK phosphorylation and cluster AChRs.
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Agrin triggers signaling mechanisms of high temporal and spatial specificity to achieve phosphorylation,
clustering, and stabilization of postsynaptic acetylcholine receptors (AChRs). Agrin transiently activates the
kinase MuSK; MuSK activation has largely vanished when AChR clusters appear. Thus, a tyrosine kinase
cascade acts downstream from MuSK, as illustrated by the agrin-evoked long-lasting activation of Src family
kinases (SFKs) and their requirement for AChR cluster stabilization. We have investigated this cascade and
report that pharmacological inhibition of SFKs reduces early but not later agrin-induced phosphorylation of
MuSK and AChRs, while inhibition of Abl kinases reduces late phosphorylation. Interestingly, SFK inhibition
applied selectively during agrin-induced AChR cluster formation caused rapid cluster dispersal later upon
agrin withdrawal. We also report that a single 5-min agrin pulse, followed by extensive washing, triggered
long-lasting MuSK and AChR phosphorylation and efficient AChR clustering. Following the pulse, MuSK
phosphorylation increased and, beyond a certain level, caused maximal clustering. These data reveal novel
temporal aspects of tyrosine kinase action in agrin signaling. First, during AChR cluster formation, SFKs
initiate early phosphorylation and an AChR stabilization program that acts much later. Second, a kinase
mechanism rapidly activated by agrin acts thereafter autonomously in agrin’s absence to further increase
MuSK phosphorylation and cluster AChRs.
Neuromuscular synapses are cellular contacts of remarkable
specialization. The presynaptic terminal is specialized to re-
lease neurotransmitters on demand, and the postsynaptic
membrane, by accumulating a high density of clustered acetyl-
choline receptors (AChRs) and associated proteins, is special-
ized to generate an endplate potential of sufficient magnitude
to reliably initiate an action potential in the muscle. To assem-
ble and maintain these structures, it is essential that pre- and
postsynaptic cells exchange signals to coordinate their differ-
entiation in time and space.
One such signaling exchange is initiated by agrin, a nerve-
derived signal that is concentrated in the synaptic basal lamina
(37). Agrin rapidly stimulates MuSK, a receptor tyrosine ki-
nase of skeletal muscle, and agrin-MuSK signaling is essential
for the formation of neuromuscular synapses (16, 20). Little is
known about the mechanisms by which agrin activates MuSK
and how MuSK activation leads to pre- and postsynaptic dif-
ferentiation. Phosphorylation of tyrosine residues in the MuSK
activation loop and the juxtamembrane region, however, is
essential for agrin-induced clustering of AChRs (26, 59). In-
terestingly, agrin-induced activation of MuSK is transient and
has largely vanished by the time AChR clusters appear (15).
This suggests that a downstream pathway is activated and
raises the issue of whether such a pathway operates autono-
mously in the absence of continuous agrin stimulation.
Pharmacological studies indicate that MuSK stimulation in-
deed activates a downstream tyrosine kinase cascade important
in clustering of AChRs (15). Within this cascade, Src family
kinases (SFKs), which are associated with AChRs (14), rapidly
become phosphorylated and activated by agrin treatment, and
their activation lasts much longer than the activation of MuSK
(39). Crucial players in the cascade are Abl kinases, as they are
required for AChR clustering, associate with MuSK, and phos-
phorylate MuSK (10). The downstream cascade also leads to
tyrosine phosphorylation of the AChR  and  subunits (39,
55), and  phosphorylation is required for efficient clustering
and cytoskeletal interaction of the AChR (3). It remains un-
clear which kinase phosphorylates the AChR in response to
agrin, although SFKs have been implicated (40, 46), and it is
unknown if the downstream kinase cascade requires continu-
ous agrin stimulation to remain active and lead to AChR
clustering.
Following their formation in embryogenesis, neuromuscular
synapses become structurally and functionally mature during
early postnatal life. Although agrin-MuSK signaling is likely to
have a role in synaptic maturation, additional signaling mech-
anisms may regulate synaptic maturation and maintenance
without having an essential role in synapse formation (29, 45,
58). Separate pathways for synapse formation and synapse
maintenance and maturation are illustrated in mice lacking
utrophin and dystrophin or in mice lacking -dystrobrevin, a
component of the dystrophin/utrophin-glycoprotein complex;
in these mice, neuromuscular synapses form but fail to mature
properly (22, 23). Notably, in the absence of -dystrobrevin,
synaptic AChR clusters are normal at birth but increasingly
* Corresponding author. Mailing address: Brain Research Institute,
University of Zu¨rich, Winterthurerstrasse 190, CH-8057 Zu¨rich, Swit-
zerland. Phone: 41 1 635 33 10. Fax: 41 1 635 33 03. E-mail: chfuhrer
@hifo.unizh.ch.
† P.M. and A.A.C. contributed equally to this work.
7841
fragment postnatally, indicating a defect in the mechanisms
that stabilize the postsynaptic membrane (23). Similarly, in
cultured myotubes lacking -dystrobrevin, AChR clusters form
normally in response to agrin stimulation, but these clusters
are unstable and disperse rapidly when agrin is withdrawn from
the myotubes (23). -Dystrobrevin acts at least in part via
tyrosine phosphorylation of the -dystrobrevin-1 isoform, sug-
gesting the involvement of a tyrosine kinase in postsynaptic
stabilization (21).
Good candidates for such a kinase are SFKs. We previously
analyzed mice that were mutant for Src and Fyn, Src and Yes,
or Fyn and Yes and found that neuromuscular synapses appear
normal in mice lacking these pairs of SFKs (46). SFKs, how-
ever, are important for stabilizing AChR clusters, as AChR
clusters, which form normally in cultured myotubes lacking
both Src and Fyn, are unstable following the withdrawal of
agrin and rapidly fragment into microclusters in these mutant
cells (46). Similarly, Src and Fyn stabilize AChR clusters that
were induced by laminin, indicating their importance in more
than one clustering pathway (36). Together, these observations
raise the question of whether the activation of SFKs upon agrin
stimulation is linked with the role of SFKs in AChR cluster
stabilization.
To elucidate the temporal action of tyrosine kinases in agrin
signaling, we have investigated how the downstream kinase
cascade acts in clustering and stabilization of AChRs. We find
that upon agrin stimulation, SFKs phosphorylate the AChR
and MuSK early but not later and that SFKs recruit a pathway
for stabilization of AChR clusters during initiation of cluster
formation. Furthermore, we find that a single 5-min agrin
pulse, followed by efficient washing, is sufficient to trigger max-
imal AChR clustering, first detectable several hours following
the pulse, indicating that agrin rapidly activates an autono-
mous pathway that subsequently runs in the absence of con-
tinual agrin stimulation.
MATERIALS AND METHODS
Expression of agrin and cell culture. Soluble neurally derived agrin (C-
Ag12,4,8) was produced in COS cells as previously described (15). Cell culture
reagents were purchased from Life Technologies (Basel, Switzerland). C2C12
(C2), src/ fyn/ myoblasts (clones DM11 and DM15), and the corresponding
wild-type myoblasts (clones SW5 and SW10) were grown and fused to form
myotubes as previously described (15, 46). Most of the experiments were done
with clones SW5 and DM11, but the other clones gave identical results.
Antibodies and inhibitors. Antibodies against phosphotyrosine (PY20, 4G10);
the AChR  and  subunits (mAb88); the conserved C terminus of Src, Fyn, and
Yes (src-CT); MuSK; the AChR  subunit (mAb124); and the AChR  subunit
(mAb35) were all used as previously described (35, 39). Sequence-specific phos-
phorylation of SFKs (at Y215, Y418, or Y529) was detected by rabbit polyclonal
phosphopeptide-specific antibodies purified by sequential epitope-specific chro-
matography as performed by the supplier (BioSource Europe, S.A., Brussels,
Belgium). These antibodies were generated against the phosphorylation sites and
flanking peptides of Src but are expected to cross-react with Fyn and Yes based
on the high sequence conservation. Rabbit polyclonal antibodies raised against
the C terminus of agrin that were used in Western blots were detailed previously
(48). To analyze the effect of anti-agrin antibody mAb33 on clustering, agrin was
preincubated for 1 h at room temperature with the antibody (0.025 to 0.1 mg/ml)
and then was applied to myotubes for 6 h. In experiments with brief agrin pulses,
agrin was added for 5 min. Agrin was withdrawn and cells were washed with
medium, and then they were incubated with media containing mAb33. mAb33
was generated by Werner Hoch (University of Houston) (27) and is commer-
cially available through Stressgen Biotechnologies (Victoria, Canada).
To examine the role of SFKs in agrin-induced AChR phosphorylation and
clustering, a novel, potent, and SFK-selective tyrosine kinase inhibitor,
CGP77675 (kindly provided by M. Susa, Novartis, Basel, Switzerland) was used
(38). Myotubes were preincubated for 90 min in medium containing 10 M
CGP77675, stimulated with agrin in the presence of inhibitor, and subjected to
precipitation assays or immunocytochemical stainings as described below. For
AChR clustering assays, we occasionally re-added inhibitor (10 M) several
times during agrin incubation to ensure its full activity. We obtained the same
results whether or not we re-added CGP77675. CGP77675 had no significant
effect on spontaneous AChR clustering or cell morphology. In controls,
CGP77675 was omitted and the carrier (dimethyl sulfoxide) was used alone. An
established concentration of CGP77675 for use in cell cultures is 10 M (38, 44),
and this is 250-fold greater than the 50% inhibitory concentration for Src auto-
phosphorylation in vitro and 500- to 2,000-fold greater than the 50% inhibitory
concentration for phosphorylation of peptide substrates in vitro (38). We also
used a range of concentrations of inhibitor, from 3 to 30 M, for AChR clus-
tering and phosphorylation and obtained results similar to those for 10 M,
although effects were a bit less at 3 M.
To block Abl kinases, C2 myotubes were treated with 10 M STI 571 (10),
analogous to CGP77675. We also used 20 M STI 571 and obtained the same
results.
Precipitation assays and immunoblot analysis. To examine the effects of
CGP77675 on agrin-induced phosphorylation, myotubes were pretreated for 90
min with the inhibitor, followed by 0.5 nM agrin for 5 or 40 min in the presence
of CGP77675. Cell lysates were split into two parts and were analyzed either by
MuSK or AChR precipitation followed by phosphotyrosine immunoblotting as
previously described (39). To precipitate AChRs, biotin-coupled -bungarotoxin
(-BT) was used, followed by streptavidin-coupled agarose beads (39). Phospho-
tyrosine bands were identified based on their molecular weight and by reprobing
immunoblots with antibodies reactive with the AChR subunits or with SFKs
(src-CT). MuSK was precipitated with polyclonal anti-MuSK antibodies and
protein A-Sepharose (15). Quantitation was performed by densitometric scan-
ning as described previously (39). Signals from cells that were mostly not treated
with agrin were used as 100% control. For some experiments depicted in the
figures, signals of cells treated with agrin for 5 min were used as 100% controls,
because in untreated cells signals were sometimes too small (or were even
undetectable) to serve as a reference. In all cases tyrosine phosphorylation of
AChRs, AChR-associated SFKs, and MuSK were clearly increased by 5 min of
agrin treatment compared to tyrosine phosphorylation of untreated cultures. In
all quantitations of tyrosine phosphorylation of AChRs or AChR-associated
proteins (using -BT-precipitation), signals were normalized for the amount of
precipitated AChRs, as revealed by reprobing blots for the AChR  or  and 
subunits. Effects of STI 571 on phosphorylation were studied in an analogous
way.
Single brief agrin pulse. Myotubes were stimulated with 0.1 or 0.5 nM agrin
for 5 or 40 min, washed twice with fusion medium containing no agrin, and
incubated with medium lacking agrin. After the appropriate times, 8 h for
clustering, AChR phosphorylation and clustering were analyzed. To analyze the
role of SFKs, myotubes were pretreated with CGP77675 and were stimulated
with agrin followed by agrin withdrawal, all in the presence of CGP77675.
Quantitation of agrin and MuSK. To quantify cell-bound agrin per milligram
of cellular protein, lysates made from agrin-treated myotubes were analyzed by
agrin immunoblotting. Using an agrin standard, we calculated cell-bound agrin
(in femtamoles) per milligram of cellular myotube protein in the lysates loaded
onto the sodium dodecyl sulfate (SDS) gel. The smallest detectable signal (2.4
fmol/mg), which represents the detection limit of this procedure, indicates the
maximal amount of agrin that may remain cell bound after a 5-min pulse and
withdrawal (see Fig. 8A). Quantitation of agrin was performed three times, with
similar results.
To estimate the amount of MuSK per milligram of cellular protein, MuSK-
antibodies known to work properly in precipitation assays (15) were covalently
coupled to protein A-Sepharose beads by using dimethyl pimelimidate (25). As
control, preimmune serum was coupled. Myotube lysates, typically containing 12
mg of cellular protein, were incubated with MuSK antibodies and the beads were
pelleted. Pellets, containing precipitated MuSK, and supernatants, containing
soluble MuSK, were boiled in SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) buffer. Two steps were performed to estimate MuSK. First, 90% of
pellets were subjected to SDS-PAGE and SYPRO Ruby staining, a highly sen-
sitive luminescent protein stain of superior linearity ideal for quantitation of a
wide range of proteins (Molecular Probes, Eugene, Oreg.) (2). Precipitated
MuSK, identified based on its molecular weight and absence in the preimmune
control precipitation, was quantified by blue-light illumination and densitometric
scanning using a parallel bovine serum albumin (BSA) standard. Typically, 100
ng of MuSK was found in these precipitates. Second, 10% of pellets and 2% of
supernatants were analyzed by MuSK immunoblotting and densitometric scan-
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ning, revealing that typically 60% of total MuSK in the original myotube lysate
was precipitated while 40% remained in the supernatant. This estimation of
MuSK was performed three times and yielded an average amount of 179.1 74.6
(mean  standard error of the mean [SEM]) fmol of MuSK/mg of cellular
protein. Although based on an indirect method of MuSK quantitation, this
estimation implies that the amount of agrin remaining myotube associated after
withdrawal is only ca. 1% of the level of MuSK.
Immunocytochemical staining, fluorescence microscopy, and quantitation of
clusters. AChRs were visualized by incubating myotubes with 100 nM tetra-
methylrhodamine-conjugated -BT (Molecular Probes) in fusion medium for 1 h
at 37°C followed by fixation (35). Cells were mounted in glycerol containing
p-phenylenediamine (Sigma) to reduce fluorescence fading and were examined
with a fluorescence microscope (Axioskop 2; Carl Zeiss, Jena, Germany). To
quantitate clusters, 10 to 20 random fields of myotubes taken at 	400 magnifi-
cation were chosen by phase contrast, and signals were counted as clusters as
described previously (35), i.e., if signal intensity was clearly distinguishable from
diffuse staining and was well above background levels and if signals had an
elongated shape. Within each experiment the number of AChR clusters per
myotube was averaged. Data from at least three such experiments were used to
calculate means  SEM.
RESULTS
Agrin increases phosphorylation of the main autophosphor-
ylation site in AChR-associated SFKs. In our initial experi-
ments, we sought to determine how activation of Src and Fyn,
bound to the AChR, is regulated. A hallmark of SFK activation
is phosphorylation of a tyrosine in the activation loop, Y418,
which represents the main autophosphorylation site (Fig. 1A)
(51). In addition, dephosphorylation of a C-terminal phospho-
tyrosine, Y529, leads to maximal and sustained activity. De-
phosphorylation of Y529 displaces the intramolecular pY529-
SH2 domain interaction, enhancing kinase reconfiguration and
activity (51). Thus, by monitoring Y418 phosphorylation we can
assess SFK activation, while the status of Y529 is an indication
of the strength and duration of activation.
We monitored phosphorylation of AChR-associated SFKs
by treating C2 myotubes with agrin and precipitating AChRs
(Tox-P) using -BT as reported previously (39). We stimulated
myotubes with 0.5 nM agrin for 40 min, because phosphoryla-
tion of MuSK, SFKs, and AChRs is maximal at this time (15,
39). As shown by immunoblotting, overall tyrosine phosphor-
ylation of AChR-bound SFKs was indeed increased by agrin
(Fig. 1B). By probing Western blots with phosphopeptide-
specific antibodies to either pY418, pY215, or pY529 in SFKs we
found that Y418 phosphorylation increases 2.8-fold following
agrin stimulation (Fig. 1C). In contrast, phosphorylation of
Y215, residing within the SH2 domain, decreased 1.7-fold,
while agrin did not diminish phosphorylation of Y529 (Fig. 1C).
These changes in phosphorylation at individual tyrosine resi-
dues correspond well with the overall 2.2-fold increase in ty-
rosine phosphorylation of SFKs induced by agrin (39) (see also
Fig. 1B) and suggest that this overall increase largely reflects
the increased phosphorylation of Y418. Taken together, agrin
stimulates phosphorylation at the activation loop tyrosine Y418
in AChR-associated SFKs, indicating their activation. Because
pY529 is not dephosphorylated, this activation appears sub-
maximal and sustained by other mechanisms.
Early but not later agrin-induced phosphorylation is inhib-
ited by CGP77675, a SFK-selective tyrosine kinase inhibitor.
In addition to phosphorylation of AChR-associated SFKs,
agrin induces tyrosine phosphorylation of AChR  and  sub-
units (39), raising the possibility that the AChR may be a direct
substrate for SFKs. To test this idea, we blocked SFK activity
by treating myotubes with 10 M CGP77675, a potent and
SFK-specific inhibitor. We stimulated myotubes, pretreated
with inhibitor, with agrin for 5 min, because phosphorylation is
first detectable at this time (15). CGP77675 was continuously
present during the agrin incubation for 40 min, and we ana-
lyzed -BT–AChR precipitates by phosphotyrosine immuno-
blotting (Fig. 2). We observed that AChR  subunit phosphor-
ylation, induced by a 5-min agrin treatment, is inhibited by
CGP77675, whereas  subunit phosphorylation, induced by a
40-min treatment, is not affected (Fig. 2A). Although these
experiments indicated that SFKs are ultimately dispensable for
stimulating AChR  subunit phosphorylation, we were con-
cerned that the failure of CGP77675 to inhibit this phosphor-
ylation at 40 min may be due to a loss of CGP77675 activity at
this time. We therefore determined whether the inhibitor re-
mained active during agrin incubation by measuring the level
of total cellular tyrosine phosphorylation in myotube lysates.
Figure 2B shows that phosphorylation was equally reduced in
CGP77675-treated myotubes incubated with agrin for 5 or 40
FIG. 1. Agrin increases phosphorylation of Y418 in AChR-associ-
ated SFKs. (A) A cartoon showing the position of tyrosine residues
(Y215, Y418, Y529) important in regulation of SFKs. (B) From C2
myotubes treated with 0.5 nM agrin, AChRs were precipitated with
biotin--BT (Tox-P), followed by immunoblotting. Controls included
addition of 10 M free -BT (T). The blot was probed with pan-Src
antibodies (src-CT), followed by antiphosphotyrosine and AChR (
and  subunit) reprobing. (C) Blots were probed with antibodies
against Y418, Y215, and Y529 phosphopeptides, and bands originating
from SFKs (arrows) that were identified by src-CT reprobing were
quantitated. Background signals from control precipitations (T)
were subtracted from AChR precipitations to yield quantitations
(means SEM of at least four experiments). An asterisk indicates that
the result differs significantly from that for non-agrin-treated control
(P 
 0.05; two-tailed paired t test).
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min. Thus, CGP77675 is equally efficient at reducing total
cellular tyrosine phosphorylation at 5 and 40 min but is effec-
tive only in inhibiting AChR  subunit phosphorylation at 5
min following agrin stimulation. Furthermore, we used higher
CGP77675 concentrations, up to 30 M, in these assays and
obtained the same results (P. Mittaud and C. Fuhrer, unpub-
lished observations).
Because AChR  phosphorylation was greater after 40 min
of agrin treatment than after 5 min (Fig. 2A), we were con-
cerned that our assay might not detect an inhibitory effect of
CGP77675 at 40 min. We therefore stimulated myotubes with
20 nM rather than 1 nM agrin, which induced strong AChR 
phosphorylation at 5 min, similar to the  phosphorylation
observed at 40 min using 1 nM agrin. We found that
CGP77675 nonetheless blocks this strong early  phosphory-
lation but not the late  phosphorylation (Fig. 2C). Thus, SFK
activity is required for early but not later tyrosine phosphory-
lation of the AChR  subunit.
We next studied the effect of CGP77675 on agrin-induced
phosphorylation of AChR  subunits, AChR-associated SFKs,
and MuSK. Quantitation showed that early (5 min), but not
late (40 min), phosphorylations of AChR , AChR-bound
FIG. 2. CGP77675 inhibits early but not late phosphorylation induced by agrin. C2 myotubes were treated with 1 nM agrin in the presence or
absence of 10 M CGP77675 (CGP) and were processed by -BT (A, C, D, E) or MuSK (F) precipitation and phosphotyrosine immunoblotting
(pTyr-blot). Proteins of interest were identified based on their molecular weight and reprobing results (data not shown). (A) Quantitation of AChR
 phosphorylation shows that CGP77675 inhibits early (5 min) but not late (40 min)  phosphorylation. (B) As control for CGP77675 efficiency,
total lysates were analyzed by phosphotyrosine immunoblotting. The reduction in phosphorylation of cellular proteins shows that CGP77675 is
active and inhibits SFKs. (C) Even when using 20 nM agrin to obtain strong AChR  phosphorylation after 5 min, CGP77675 blocks early but not
late (1 nM agrin for 40 min) phosphorylation. (D to F) Densitometric quantitation shows that CGP77675 inhibits early but not late phosphorylation
of AChR  subunits, AChR-associated SFKs, and MuSK. All quantitations represent means  SEM of at least four experiments. An asterisk
indicates that the result differs significantly from that for 5 min of agrin treatment without inhibitor, with a P value of 
0.05 (a double asterisk
indicates P 
 0.005), by two-tailed paired t test. Tox-P, precipitation by biotin--BT.
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SFKs, and MuSK are inhibited by 10 M (Fig. 2D to F) or 30
M CGP77675 (data not shown). To exclude the possibility of
nonspecific inhibition of other, non-Src family kinases by
CGP77675, we also used this inhibitor at lower concentrations,
down to 3 M, in phosphorylation experiments of AChR ,
MuSK, and cellular proteins. We found effects similar to those
shown in Fig. 2A, B, and F. Furthermore, we used another SFK
inhibitor, PP2 (10 M) (46), in such assays and again obtained
comparable results (P. Mittaud and C. Fuhrer, unpublished).
Together, these data indicate that SFK activity is important
for phosphorylation of AChR  and  subunits of SFKs and of
MuSK within the first 5 min of agrin stimulation but not after
40 min of agrin stimulation. Thus, these proteins may be direct
substrates for agrin-activated SFKs at this early step, whereas
later they are likely phosphorylated by other kinases. Interest-
ingly, this also applies for SFKs themselves, because they are
inactivated by CGP77675 at 40 min of agrin treatment as
judged by impaired substrate phosphorylation (Fig. 2B), while
their own overall phosphorylation is not affected (Fig. 2E).
Thus, under these particular conditions of CGP77675 treat-
ment, SFKs, although catalytically inactive, may be phosphor-
ylated by other kinases, and one good candidate for such a
kinase is MuSK, because MuSK interacts with SFKs (40).
In the absence of Src and Fyn, AChRs but not MuSK are
phosphorylated by SFKs early in agrin signaling. Cultured
myotubes contain three major SFKs: Src, Fyn, and Yes (14).
To analyze whether Src and Fyn are the critical SFKs that
mediate early agrin-induced phosphorylation, we examined
myotubes derived from mice lacking both Src and Fyn (src/
fyn/ myotubes) (46). Figure 3A shows that even in these
cells, a 5-min agrin treatment increases phosphorylation of
AChR  subunits to levels similar to those of wild-type or C2
myotubes (see Fig. 2A for comparison). As the SFK Yes is
upregulated and appears to associate with AChRs in src/
fyn/ myotubes (46), Yes could be responsible for such phos-
phorylation. We therefore applied CGP77675, which efficiently
inhibits Yes (38), to these cells and found that it indeed inhib-
ited early but not late AChR  subunit phosphorylation (Fig.
3A). Thus, in src/ fyn/ myotubes, early AChR  phos-
phorylation requires an SFK, most likely Yes, whereas later 
phosphorylation involves a non-SFK.
Interestingly, CGP77675 inhibited early MuSK phosphory-
lation in wild-type but not in src/ fyn/ myotubes (Fig. 3B).
This shows that in src/ fyn/ myotubes Yes cannot replace
Src and Fyn in mediating MuSK phosphorylation and that a
non-SFK is responsible for early and late MuSK phosphoryla-
tion in these mutant cells. Furthermore, overall levels of MuSK
phosphorylation appear slightly higher in the mutant (Fig. 3B).
This suggests that SFKs may regulate MuSK in both positive
and negative ways: if all SFKs are present (wild-type situation),
their activity is required for early MuSK phosphorylation; if Src
and Fyn are missing (src/ fyn/ situation), MuSK phos-
phorylation occurs more efficiently, is independent of SFK
activity, and may occur from MuSK itself or from Abl (10).
Thus, Src and Fyn, by interacting with MuSK (40), may nor-
mally hinder MuSK and/or Abl from phosphorylating MuSK
maximally. In the absence of Src and Fyn, MuSK and/or Abl
activity may become upregulated to phosphorylate MuSK to a
higher degree. The complex of MuSK, Abl, Src, and Fyn may
allow fine tuning of the phosphorylation status of MuSK, which
is a central regulator in postsynaptic assembly.
Abl kinases mediate late phosphorylation of AChRs and
MuSK. Because Abl kinases are required for AChR clustering
(10), we investigated whether they cause phosphorylation of
AChRs and MuSK later in agrin signaling. As before for
CGP77675, we pretreated C2 myotubes with 10 M STI 571, a
specific Abl inhibitor (10), and added agrin for 5 or 40 min in
the continuous presence of STI 571. Phosphorylation of AChR
FIG. 3. In myotubes lacking Src and Fyn, early AChR  subunit
phosphorylation induced by agrin is inhibited by CGP77675 (CGP),
while MuSK phosphorylation is not affected. (A) src/ fyn/ and
wild-type myotubes were treated with 1 nM agrin and CGP77675.
Phosphorylation of AChR  subunits was analyzed, followed by rep-
robing for the AChR  subunit. (B) MuSK was precipitated from
wild-type and src/ fyn/ myotubes and was analyzed by phospho-
tyrosine immunoblotting (pTyr-blot). As control, the MuSK antibody
was omitted (Ab). For all quantitations, which reflect means  SEM
of at least three experiments, signals of cells treated with agrin for 5
min without inhibitor were set to 100%. An asterisk indicates that the
result differs significantly from that for 5 min of agrin treatment with-
out CGP77675 (P 
 0.05 in panel A; P 
 0.006 in panel B; one-sample
student’s t test). ToxP, precipitation by biotin--BT; IP, immunopre-
cipitation.
VOL. 24, 2004 TEMPORAL KINASE ACTION IN AGRIN SIGNALING 7845
 subunits and of MuSK was substantially reduced at 40 min of
agrin treatment (Fig. 4). At 5 min, AChR  phosphorylation
was slightly reduced, while MuSK was not affected (Fig. 4).
These data show that Abl kinases preferably act to phosphor-
ylate AChRs and MuSK later (40 min) in agrin signaling, in
contrast to SFKs, which cause phosphorylation early (5 min) in
agrin signaling.
Inhibition of SFKs during the formation of AChR clusters
leads to a defect in the stability of AChR clusters. To investi-
gate how SFK activation relates to AChR clustering, we first
examined the effect of CGP77675 on the formation of clusters
induced by agrin. As reported previously for other SFK inhib-
itors, PP1 and PP2 (46), 10 M CGP77675 had no discernible
effect on the overall number, length, shape, or intensity of
AChR clusters induced by agrin in C2, wild-type myotubes,
and src/ fyn/ myotubes (Fig. 5A). We observed the same
results when we re-added CGP77675 several times during
agrin treatment or when we used higher concentrations (30
M; data not shown). Thus, SFK activity is not required for
agrin-induced AChR cluster formation.
Once induced by agrin, AChR clusters are remarkably stable
and disperse only slowly (half-life [t1/2]  10 to 20 h) following
withdrawal of agrin (46). The stability of these AChR clusters
is dependent upon SFKs: in myotubes lacking Src and Fyn,
agrin-induced AChR clusters disperse rapidly (t1/2  80 to 120
min) following agrin withdrawal (46). We therefore asked
whether the agrin-stimulated phosphorylation of SFKs, which
is maximal after 40 min (Fig. 1) (39), may have a role in
stabilizing AChR clusters, which form hours later.
For this purpose, we treated myotubes with CGP77675 and
agrin, followed by withdrawal of both CGP77675 and agrin.
AChR clusters formed normally but then rapidly dispersed
upon withdrawal, with a t1/2 of about 3 h (Fig. 5B). In contrast,
when CGP77675 was present during the withdrawal but not the
agrin induction period, the stability of AChR clusters was nor-
mal (Fig. 5C). These findings demonstrate that SFKs act dur-
ing the agrin induction period to stabilize AChR clusters hours
after agrin withdrawal (Fig. 5B). In addition, these results
indicate that the subsequent resumption of SFK activity, dur-
ing the agrin withdrawal period, is insufficient to stabilize
AChR clusters that formed while SFKs were inhibited. We
verified this resumption by measuring total tyrosine phosphor-
ylation of cellular proteins by immunoblotting and found it to
be normal at the end of the withdrawal period (data not
shown).
A single brief agrin pulse is sufficient to trigger long-lasting
phosphorylation of MuSK and AChR . Agrin (0.5 nM) in-
duces phosphorylation of MuSK and AChRs within 5 min (15)
(Fig. 2). In the continuous presence of agrin, these early phos-
phorylations increase substantially, ca. fourfold, to reach a
peak after 40 min (15) (see also Fig. 9). Six to 8 h later, when
AChR clusters have formed, MuSK phosphorylation has
largely vanished but is still easily detectable, while AChR phos-
phorylation stays relatively high (15). Thus, agrin triggers a
long-lasting downstream tyrosine kinase activity (39) and ulti-
mately leads to clustering of AChRs and many other proteins
after several hours. It remains unknown whether all of these
aspects are initiated within the first minutes of agrin action,
whether agrin’s presence is still required thereafter, or whether
the downstream cascade, once initiated, is self sustaining and
operates autonomously.
Therefore, we studied the consequences of a brief agrin
treatment. C2 myotubes received a single pulse of agrin (0.5
nM) for 5 or 40 min, followed by withdrawal of agrin, extensive
washing, and incubation in agrin-free medium for 8 h (Fig.
6A). The level of AChR  subunit phosphorylation following
the brief pulse was compared to the level of phosphorylation
induced by continuous agrin stimulation for 8 h. Surprisingly, 
phosphorylation was the same in all of these treatments, show-
ing that rapid agrin-induced AChR  phosphorylation is main-
FIG. 4. STI 571 inhibits late AChR  and MuSK phosphorylation
induced by agrin. C2 myotubes were treated as described in the legend
to Fig. 2, but STI 571 was used to inhibit Abl kinases. Phosphotyrosine
blots were reprobed with antibodies against AChR  subunits (A) or
MuSK (B). Quantitation (means  SEM from at least eight experi-
ments) revealed a pronounced reduction by STI 571 in phosphoryla-
tion of AChR  subunits and MuSK at 40 min of agrin treatment (**,
significant difference from corresponding inhibitor-free sample, P 

0.01; *, P 
 0.05; two-tailed paired t test). Tox-P, precipitation by
biotin--BT; pTyr-blot, phosphotyrosine immunoblot; IP, immunopre-
cipitation.
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tained long after agrin has been withdrawn (Fig. 6A). Similar
results were obtained for MuSK: a single brief agrin pulse (5
min) was sufficient to induce long-lasting MuSK phosphoryla-
tion, equivalent to that found in myotubes treated continuously
with agrin for 8 h (Fig. 6B). These results demonstrate that
agrin acts within 5 min to stimulate a signaling pathway that
thereafter is maintained and runs autonomously in the absence
of further agrin stimulation.
A single brief agrin pulse leads to efficient AChR clustering.
We examined whether this autonomous pathway, rapidly trig-
gered by agrin, also leads to normal AChR clustering. For this
purpose we added agrin for 5 or 40 min, withdrew agrin,
washed the cells extensively, incubated them in agrin-free me-
dium, and quantitated AChR clusters 8 h later. We observed
no significant differences in the number, size, or density of
FIG. 5. SFK activity during cluster formation is required for cluster
stabilization later on. (A) Myotubes were stimulated overnight with 0.5
nM agrin in the presence or absence of CGP77675 (CPG), stained with
rhodamine--BT, and analyzed by fluorescence microscopy. AChR
clustering was quantitated and is shown as the percentage of untreated
cells (C, control) (means  SEM of at least three experiments). An
asterisk indicates that the result differs significantly from that for the
respective untreated cells (P 
 0.03) but not from each other (P 
0.09; two-tailed paired t test), showing that CGP77675 does not inhibit
agrin-induced formation of AChR clusters. (B) C2 myotubes were
treated with 0.5 nM agrin for 8 h in the presence (squares) or absence
(diamonds) of CGP77675, followed by withdrawal (for 3 or 16 h) of
both CGP77675 and agrin, as indicated by arrows. AChR clustering
was quantitated as described for panel A, showing no difference in the
number of clusters formed, but the clusters dispersed more rapidly in
CGP77675-treated cells (*, P 
 0.03; **, P 
 0.001; two-tailed paired
t test). (C) C2 myotubes were stimulated for 8 h with agrin, followed by
withdrawal of agrin and addition (squares) or no addition (diamonds)
of CGP77675 into the agrin-free medium. After 3 or 16 h of with-
drawal, AChR clustering was quantified as described for panel A,
revealing no differences between CGP77675-treated and untreated
cells (P  0.2).
FIG. 6. A single 5-min agrin pulse triggers long-lasting MuSK and
AChR  phosphorylation. C2 myotubes were treated for 8 h continu-
ously with 0.5 nM agrin. Parallel cultures were incubated for 5 or 40
min with 0.5 nM agrin, followed by agrin withdrawal, washing, and
incubation in agrin-free medium for 8 h. All lysates were then split into
two parts and were analyzed either by AChR (A) or by MuSK (B) pre-
cipitation, followed by phosphotyrosine immunoblotting (pTyr-blot).
As controls, we added a 10 M free -BT (T in panel A) or omitted
the lysate or the MuSK antibody (Ab in panel B). (A) Quantitation
represents the means  SEM of three experiments and shows no
significant differences between the pulsed or continuous agrin treat-
ments (P  0.63). (B) Quantitation represents the means of two
experiments that showed very small variations between each other. IP,
immunoprecipitation.
VOL. 24, 2004 TEMPORAL KINASE ACTION IN AGRIN SIGNALING 7847
AChR clusters between the pulsed 5- or 40-min treatment and
the continuous 8-h treatment with agrin (Fig. 7). We further
investigated whether this AChR clustering is dependent on
SFK activity by applying CGP77675. The inhibitor had no
significant effect on agrin-induced AChR clustering, even when
this clustering was induced by a single brief pulse of agrin as
short as 5 min (Fig. 7B). Thus, a brief agrin treatment triggers
a mechanism that runs autonomously, in the absence of further
agrin stimulation, to cause long-lasting MuSK and AChR
phosphorylation and efficient AChR clustering. This cluster-
ing, like continuous agrin treatment, is independent of SFK
activity.
It was important to establish that our agrin withdrawal pro-
tocol removed the vast majority of cell-bound agrin and that
clustering and phosphorylation were not caused by small
amounts of agrin potentially remaining after withdrawal. We
performed two control experiments to address the issue of
whether agrin binds to cells within a 5- or 40 min pulse. First,
we stimulated myotubes with 0.5 nM agrin for 5 or 40 min and
then transferred the agrin-containing supernatant to a separate
myotube culture. Because 0.5 nM soluble agrin is below satu-
ration for AChR clustering and phosphorylation (8), a de-
crease in the concentration of agrin should reduce AChR clus-
tering and phosphorylation. We found, however, that the
transferred supernatant induced AChR clustering and  sub-
unit phosphorylation as efficiently as agrin that had not been
exposed to myotubes (P. Mittaud and C. Fuhrer, unpublished).
Thus, as no detectable agrin activity was absorbed from agrin-
containing media within 5 or 40 min, these data imply that very
little agrin binds to myotubes within that time frame. Second,
agrin was applied to cells for 5 or 40 min and was withdrawn
for 8 h. After the 8 h, the withdrawal medium was transferred
to other myotubes, where it failed to induce AChR clustering
or  phosphorylation (P. Mittaud and C. Fuhrer, unpublished).
Thus, after a brief agrin pulse followed by withdrawal, insuffi-
cient agrin is present in the withdrawal medium to stimulate
AChR clustering, implying that only low levels of agrin, if any,
remain attached to myotubes after the pulse and wash.
We next directly visualized, by immunoblotting, agrin that
remained attached to myotubes following a brief treatment
and withdrawal. The immunoblot assay was very sensitive: by
densitometric scanning and comparison to an agrin standard of
known concentration, we calculated that the detection limit of
agrin in the immunoblot is 2.4 fmol/mg of cellular protein.
While cell-bound agrin was readily detectable (300 fmol/mg)
after a continuous 8-h incubation with 0.5 nM agrin (Fig. 8A,
lane 6), cell-bound agrin was not detectable after a 5-min pulse
followed by withdrawal (Fig. 8A, lanes 2 and 3). Following a
40-min pulse and a 40-min withdrawal period, low levels of
agrin were detectable; following a longer withdrawal period (8
h), myotube-associated agrin was no longer detectable (Fig.
8A, lanes 4 and 5). As the extent of AChR clustering is the
same in myotubes treated with agrin for 5 min followed by an
8 h withdrawal and in myotubes treated continuously with
agrin for 8 h (Fig. 7), the extent of AChR clustering is not
correlated with the amount of agrin remaining associated with
the myotubes after the pulse (Fig. 8A). Thus, the remaining
agrin, if present at all, is not critical for clustering. Rather, the
brief stimulation with agrin appears sufficient to trigger a re-
sponse that occurs several hours later in the absence of agrin.
To rule out that MuSK-bound agrin may remain on MuSK
after withdrawal but may represent only a small portion of
myotube-associated agrin not detectable by our assay, we used
an indirect method to measure the level of MuSK protein. We
first precipitated MuSK from myotube lysates by using bead-
coupled MuSK antibodies (Fig. 8B). The amount of precipi-
tated MuSK was estimated using a SYPRO Ruby protein stain
and a parallel BSA standard. Second, the efficiency of this
precipitation was calculated by a parallel MuSK-Western blot,
comparing precipitated with remaining soluble MuSK (Fig.
8C). These estimations yielded an amount of 179.1 fmol of
MuSK/mg of cellular protein (see Materials and Methods for
details). This value is likely an underestimation; due to the
background in the SYPRO Ruby stain, we probably underes-
timate the amount of precipitated MuSK. Nonetheless, our
estimation demonstrates that in myotubes the level of MuSK
(179.1 fmol/mg) is much higher than the level of agrin remain-
ing cell bound after withdrawal (
2.4 fmol/mg). Because our
recombinant agrin (C-terminal half of agrin, or C-Ag12,4,8) (8)
not only binds to the MuSK complex but also to heparin and
FIG. 7. A single 5-min agrin pulse leads to efficient AChR cluster-
ing that is not affected by CGP77675 (CGP). In the presence or
absence of CGP77675, C2 myotubes were continuously treated with
0.5 nM agrin for 8 h or for 5 or 40 min followed by withdrawal of agrin
for 8 h. AChRs were stained with rhodamine--BT and were analyzed
by fluorescence microscopy. Scale bar, 40 m. (B) The numbers of
AChR clusters per myotube are shown as the percentage of untreated
cells (C, control) (means  SEM of at least five experiments). An
asterisk indicates that the result differs significantly from that of the
control (P
 0.01) but not from each other (P 0.09; two-tailed paired
t test).
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-dystroglycan (17), the actual level of agrin remaining MuSK
bound may be substantially less than 2.4 fmol/mg. Taken to-
gether, these data strongly suggest that after withdrawal the
vast majority of agrin was released from myotubes and from
MuSK on these myotubes.
Finally, we analyzed the effect of an anti-agrin antibody,
mAb33 (27), on AChR clustering. When agrin was incubated
with the antibody and added to myotubes, clustering of AChRs
was severely reduced, as reported previously (27) (Fig. 8D). In
contrast, mAb33 did not inhibit AChR clustering when added
to myotubes in the withdrawal period immediately after a
5-min pulse of agrin (Fig. 8E). Although we cannot exclude the
possibility that myotube-associated agrin is inaccessible to the
antibody, these data suggest that agrin, which may be bound to
myotubes after the pulse, is no longer required for AChR
clustering.
Thus, many lines of evidence indicate that the withdrawal of
agrin was effective. First, our agrin, C-Ag12,4,8, lacks the N-
terminal domain of agrin, which is required for efficient bind-
ing to the extracellular matrix (7). The interaction of C-Ag12,4,8
with myotubes is therefore rather weak, allowing this agrin to
be washed off easily. Second, consistent with this notion, no
detectable agrin remained associated with myotubes after a
5-min agrin pulse followed by withdrawal and washing. If some
agrin remained, it did not appear critical for clustering and was
present in much smaller amounts than MuSK. This implies
that agrin was efficiently released from MuSK, although we
cannot rule out that a very small amount of agrin (ca. 1% of
MuSK) may have remained MuSK associated. Third, no agrin
activity was detectable in the medium following withdrawal.
Fourth, a blocking antibody to agrin, added during the with-
drawal phase, failed to inhibit AChR clustering initiated by a
5-min pulse of agrin. Taken together, these experiments show
that agrin acts rapidly to trigger a clustering mechanism that
subsequently acts autonomously in the absence of further agrin
stimulation.
MuSK phosphorylation increases rapidly after the agrin
pulse and leads to maximal AChR clustering in the absence of
agrin. Because agrin acts so rapidly, we examined the level of
MuSK tyrosine phosphorylation at the end of the agrin pulse
and during the withdrawal period. At 0.5 nM agrin, strong
MuSK phosphorylation was seen after 5 or 40 min (Fig. 9A).
Following an 8-h withdrawal, these levels of MuSK phosphor-
ylation led to a similar number of AChR clusters (Fig. 9B),
which were indistinguishable from a continuous 8-h agrin
treatment (Fig. 7). As expected, the rate of MuSK phosphor-
ylation was slower when myotubes were stimulated with 0.1 nM
agrin. Consequently, the level of MuSK phosphorylation was
FIG. 8. Little, if any, agrin remains cell bound after a brief agrin
pulse and is not responsible for clustering. (A) C2 myotubes were pulse
treated with agrin (0.5 nM for 5 or 40 min), followed by washing and
withdrawal for 40 min or 8 h; parallel samples were treated continu-
ously with agrin for 8 h. Cell lysates were analyzed by agrin immuno-
blotting. No agrin signal of ca. 120 kDa (representing recombinant
agrin, C-Ag12,4,8) is detectable in cells treated for 5 or 40 min followed
by 8 h of withdrawal (lanes 3 and 5). A small agrin signal is visible in
cells treated for 40 min followed by a 40-min withdrawal (lane 4), but
this does not correlate with clustering, which is the same after a 5- or
40-min pulse (see Fig. 7). (B) MuSK was immunoprecipitated (IP)
from C2 lysates, and 90% of the precipitate was analyzed by SDS-
PAGE and SYPRO Ruby protein staining. MuSK was identified based
on its molecular weight and its absence in preimmune (pre-i) control
precipitation. Using a parallel BSA standard (data not shown), the
amount of precipitated MuSK was determined in the gel (100 ng).
(C) From the same samples as those used for panel B, 10% of the
MuSK precipitate and 2% of the supernatant were analyzed by MuSK
immunoblotting. By densitometric scanning, the efficiency of the im-
munoprecipitation was calculated (60%). (D) In the presence or ab-
sence of different concentrations of anti-agrin antibody mAb33, C2
myotubes were treated for 6 h with agrin and AChR clustering was
quantified as described for Fig. 5. An asterisk indicates that the result
differs significantly from that for the control (no immunoglobulin G
[IgG]; P 
 0.001; two-tailed paired t test). (E) Myotubes were treated
with 0.5 nM agrin for 5 min, followed by withdrawal of agrin, washing,
and incubation in agrin-free medium in the presence or absence of 0.05
mg of mAb33/ml. After 8 h, AChRs were stained with rhodamine-
-BT and quantitated as described in the legend to Fig. 5. An asterisk
indicates that the result differs significantly from that for the control (P

 0.001) but not from each other (P  0.09; two-tailed paired t test).
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much less at 5 min in myotubes treated with 0.1 nM agrin than
in myotubes treated with 0.5 nM agrin but was similar at 40
min for both agrin concentrations (Fig. 9A). The extent of
clustering paralleled these phosphorylations: after a 5-min
pulse, clustering was less efficient at 0.1 than at 0.5 nM agrin,
while after a 40-min pulse, clustering was comparable at both
agrin concentrations (Fig. 9B). This implies that a certain crit-
ical level of MuSK activation must be reached within or after
the agrin pulse in order to achieve maximal clustering: 5 min of
0.1 nM agrin does not reach this level, while 5 min of 0.5 nM
agrin does.
After 5 min of agrin treatment, MuSK phosphorylation in-
creases significantly in the continued presence of agrin, reach-
ing a peak after 40 min (15). We analyzed MuSK phosphory-
lation after the 5-min agrin pulse, particularly addressing
whether this phosphorylation is further increased during the
withdrawal period. At both 0.5 and 0.1 nM agrin, MuSK phos-
phorylation indeed increased substantially after the pulse
within 10 to 35 min (Fig. 9C). In comparison, continuous in-
cubation with agrin for 40 min led to a still higher level of
MuSK phosphorylation at 40 min (Fig. 9C). After 8 h, the
continuous and pulsed agrin treatments resulted in identical
MuSK phosphorylation (see Fig. 6). These data demonstrate
that MuSK phosphorylation increases rapidly following a brief
agrin pulse, even though cell-bound agrin is not detectable
during this increase. Thus, agrin triggers a mechanism that
increases MuSK phosphorylation in the subsequent absence of
agrin. If MuSK phosphorylation reaches a certain critical level,
as is the case with a 5-min 0.5 nM agrin pulse, maximal AChR
clustering is seen after 8 h of withdrawal. If the MuSK phos-
phorylation is below this level, as in the case of a 5-min 0.1 nM
agrin pulse, maximal clustering does not occur (Fig. 9A), even
though MuSK phosphorylation still increases following with-
drawal. This defines a critical level of MuSK activation that can
be reached within minutes, beyond which the maximal AChR
clustering program is initiated even in the absence of further
agrin stimulation.
DISCUSSION
Here we reveal novel temporal patterns of tyrosine kinase
action in the agrin signaling pathway. First, we showed that
SFKs are required for phosphorylation of MuSK and AChRs
early (5 min) but not later (40 min) after agrin stimulation,
whereas Abl kinases mediate late phosphorylation. Second, we
find that SFKs act during the period of AChR cluster forma-
tion, and not thereafter, to stabilize AChR clusters following
withdrawal of agrin. Thus, during cluster initiation, SFKs re-
cruit a stabilization pathway that acts hours later. Third, we
find that a single, brief pulse of agrin is sufficient to induce a
pathway that clusters AChRs efficiently in the absence of agrin.
This autonomous pathway, once triggered, leads to a rapid
increase in MuSK phosphorylation; when a critical level of
MuSK phosphorylation is reached, the clustering program is
fully activated, leading to AChR clusters hours later.
SFK activity is dispensable for agrin-induced AChR cluster
formation. Our data clarify the role of SFKs in the formation
of AChR clusters. Previous studies yielded differing results (40,
46), which may be attributed to inadvertent inhibition of Abl by
the inhibitor PP1 (50). As Abl is required for AChR clustering
FIG. 9. The agrin-triggered autonomous pathway is maximally ac-
tivated if MuSK phosphorylation reaches a certain level. (A) C2 myo-
tubes were continuously treated for 5 min, 40 min, or overnight with
0.1 or 0.5 nM agrin, and cell lysates were analyzed by MuSK immu-
noprecipitation (IP) and phosphotyrosine immunoblotting (pTyr-blot).
As control, MuSK antibody was omitted (Ab). (B) C2 myotubes were
treated for 5 or 40 min with 0.1 or 0.5 nM agrin, followed by withdrawal
for 8 h. AChRs were stained with rhodamine--BT and were analyzed
by fluorescence microscopy. Within each pulse, the numbers of AChR
clusters per myotube treated with 0.5 nM agrin, quantitated as de-
scribed for Fig. 5, were set to 100%. *P 
 0.02 by two-tailed paired t
test. (C) Myotubes were treated for 5 min with 0.1 nM (diamonds) or
0.5 nM (squares) agrin, followed by 10 min, 35 min, or 8 h of agrin
withdrawal, MuSK immunoprecipitation, and phosphotyrosine immu-
noblotting. Parallel cells were continuously treated for 40 min with 0.5
nM agrin (triangle). After a 5-min agrin pulse, MuSK phosphorylation
increased in the withdrawal period. Quantitation shows the means 
SEM of three experiments evaluated by densitometric scanning. The
area between the drawn lines indicates a critical level of MuSK phos-
phorylation. Above this level, maximal clustering occurs even in the
subsequent absence of agrin.
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(10), high concentrations (20 M) of PP1 may have interfered
with Abl, leading to defective AChR clustering (40), whereas
lower concentrations of PP1 (5 M) may have been more
selective for SFKs, leading to normal clustering (46). Our find-
ings, combining gene elimination with more selective pharma-
cological inhibition, now demonstrate that the formation of
clusters requires very little, if any, SFK activity: in wild-type
and even src/ fyn/ cells, agrin induces normal AChR clus-
tering in the presence of CGP77675, a potent and specific
inhibitor that efficiently blocks SFKs, including Yes (38). Be-
cause Yes is the main remaining SFK in src/ fyn/ cells
(46), these data provide strong evidence that SFK activity is
not needed for AChR cluster formation.
Src family and Abl kinases mediate early and late phosphor-
ylation, respectively. In agrin-induced phosphorylation of
AChR  and  subunits, the role of SFKs has also remained
controversial (40, 46). We now find that SFK activity acts only
early (5 min) after addition of agrin. These findings may pro-
vide an explanation for the reported failure of PP1 to reduce
AChR  phosphorylation following 30 to 40 min of agrin stim-
ulation (46) and inhibition of AChR  phosphorylation by PP1
following a 10-min treatment with agrin (40). Thus, our results
establish a temporal pattern of SFK action in agrin signaling in
which these kinases are required for MuSK and AChR phos-
phorylation only early (5 min) but not later (40 min and there-
after). In contrast, Abl kinases cause MuSK and AChR 
phosphorylation, preferably late (40 min) in agrin signaling.
Phosphorylation of MuSK and AChRs is therefore under com-
plex temporal control and involves several nonreceptor ty-
rosine kinases.
Time-delayed action of SFKs in stabilization of AChR clus-
ters. We find that SFK activity is required selectively during
agrin-induced AChR cluster formation to stabilize these clus-
ters in the hours after agrin withdrawal. These observations
functionally link the SFK activation during AChR cluster for-
mation to cluster stabilization later. Because SFK activation is
maximal after 40 min of agrin treatment (39) (see also Fig. 1),
i.e., hours before AChR clusters are formed, our data imply
that SFKs already recruit a stabilization pathway when AChR
clustering has just been initiated.
As MuSK and AChR phosphorylation occur independently
of SFKs after 40 min of agrin treatment, these data suggest that
SFKs phosphorylate proteins in addition to MuSK and AChRs,
which are crucial for AChR cluster stabilization. This is in
good agreement with our observation that SFKs are not acti-
vated by C-terminal dephosphorylation (Fig. 1) but rather, by
inference, through protein interactions (51), implying the ex-
istence of other SFK-binding proteins and SFK substrates.
Agrin-induced SFK activity is thus under constant control
rather than being maximal and sustained over prolonged pe-
riods (51). Of interest is the reduction in phosphorylation of
Y215 within the SH2 domain of SFKs (Fig. 1), a domain known
to mediate protein interactions with, for example, phosphory-
lated MuSK (40). Dephosphorylation of Y215 may well render
the SH2 domain capable of binding to other proteins. A good
candidate is -dystrobrevin, whose long isoform (-dystrobre-
vin-1) mediates AChR cluster stabilization in part due to its
C-terminal tyrosine phosphorylation sites (21), which may be
SFK substrates. Other candidates are the Src substrates talin,
paxillin, -fodrin, and cortactin, which are all enriched at neu-
romuscular junctions (NMJs) and AChR clusters in myotubes
(6, 24). All these proteins interact with actin, whose polymer-
ization is a requirement for AChR clustering and may stabilize
clusters (6).
The link between cluster formation and their stabilization by
SFKs may involve differential phosphorylation of MuSK me-
diated by SFKs early (5 min) and by Abl kinases late (40 min)
in agrin signaling. Although Abl kinases can be phosphorylated
by SFKs (49), our observed effects of CGP77675 and STI 571
show that Abl acts independently of SFKs at 40 min and that
SFKs act independently of Abl at 5 min to phosphorylate
MuSK. Nevertheless, the action of the two kinases is highly
intertwined, because early-acting SFKs lead to a delayed path-
way that stabilizes AChRs clusters while late-acting Abl ki-
nases lead to a more immediate pathway that forms clusters.
This may well occur through phosphorylation of separate ty-
rosine residues in MuSK by Abl and SFKs. The juxtamem-
brane domain tyrosine (Y553) is a good candidate for Abl,
because both Y553 and Abl are required for AChR cluster
formation (10, 26, 59). Tyrosines in the N- and C-terminal
region of the MuSK kinase domain (Y576 and Y812, respec-
tively) are candidates for SFKs, because they are not essential
in the formation of clusters (26) but may still play a role in their
stabilization. Phosphotyrosines may bind to specific adaptor
proteins, leading to activation of distinct postsynaptic path-
ways. These pathways may be initiated and maintained through
the increased association of both Abl and SFKs with MuSK,
which is rapidly triggered by agrin (10, 40).
Taken together, the emerging picture is that a complex con-
taining MuSK, Abl, and SFKs is rapidly assembled by agrin.
Abl and SFKs, possibly through phosphorylation of distinct
MuSK residues, activate pathways for cluster formation and
stabilization, respectively. In addition to interacting with
MuSK (40), SFKs interact with AChRs (14) and agrin stimu-
lates association between MuSK and AChRs (13, 15). There-
fore, the stabilization program triggered by SFKs during initi-
ation of clustering is recruited to the right location, nascent
clusters at postsynaptic membrane specializations containing
MuSK and AChRs. The delay in its manifestation may be
important to ensure that the pathway becomes effective only
after the initial clusters have been formed to achieve cluster
stabilization and maturation. This delay may therefore be re-
lated to the complex elaboration of the NMJ, including the
formation of postjunctional folds and restriction of AChRs to
the crests of these folds, which occur postnatally. Thus, com-
plex interactions between MuSK, Abl, SFKs, and AChRs may
ensure that pathways for cluster formation as well as stabiliza-
tion and maturation converge in an appropriate manner both
temporally and spatially at the nascent NMJ.
A single brief agrin pulse activates an autonomous mecha-
nism that leads to AChR clustering. Our data reveal another
temporal aspect of tyrosine kinase action in agrin signaling,
because the continuous stimulation by agrin is not required for
AChR clustering. Instead, using an agrin pulse and withdrawal
protocol, we found that agrin rapidly initiates, within a single
5-min pulse, a clustering pathway that then acts autonomously
in agrin’s absence.
For other growth or differentiation factors, rapid activation
of their tyrosine kinase receptors has been intensively investi-
gated and occurs widely (56). It remains largely unknown,
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however, to what extent the continual presence of ligand is
necessary after the initial trigger to maintain the activity of
intracellular signaling. In neuregulin signaling in myogenesis,
which requires several days, and in basic fibroblast growth
factor-induced calcium influx in fibroblasts, the continuous
presence of ligand seems necessary to achieve prolonged ef-
fects (11, 42). In contrast, using an approach similar to ours, a
single brief pulse of nerve growth factor (NGF), followed by
withdrawal and inhibitory antibodies, was exploited to show
that NGF acts rapidly to trigger certain long-lasting pathways
in PC12 cells (52). The brief application of NGF, epidermal
growth factor, or basic fibroblast growth factor induced sodium
channel gene expression hours later, leading to global cell
excitability (52).
Agrin induces phosphorylation of MuSK within 5 min, but
this phosphorylation reaches a peak only after 40 min (15). We
showed here that continuous stimulation by agrin is not nec-
essary. In comparison to other receptor tyrosine kinases,
MuSK is very unusual and its tasks are far more complex, as
previously noted by others (19). MuSK not only triggers intra-
cellular signaling but also has to localize such signaling to the
correct site of a huge syncytial cell to achieve new protein
synthesis as well as relocalization of dozens of preexisting pro-
teins at the nascent postsynapse. In addition, MuSK is required
for presynaptic specialization of the nerve terminal (20). In line
with such complex roles of MuSK, experiments with chimeric
receptors have shown that, in contrast to growth factor recep-
tors, MuSK’s activated intracellular domain alone is not suffi-
cient to reproduce MuSK’s biological activity (i.e., AChR clus-
tering)—structural portions of the MuSK extracellular domain
are also important (19). Our data propose that even responses
as complex as those initiated by MuSK, involving structural
roles as well as catalytic tasks, may be triggered by a single brief
pulse of ligand. This opens new avenues to better understand-
ing signaling by complex receptor tyrosine kinases in general.
Our data show that within this rapidly triggered, autono-
mous pathway of agrin, the phosphorylation level of MuSK is
of central importance. We find that it increases rapidly even
after agrin withdrawal and, when reaching a certain critical
level within 40 min of withdrawal, leads to maximal AChR
clustering many hours later. This increase in MuSK phosphor-
ylation may originate from MuSK itself through autophosphor-
ylation or from an associated kinase. As mentioned above,
MuSK occurs in a multiprotein complex where it associates at
least with SFKs (40), Abl kinases (10), some AChRs (13, 15),
Dishevelled (34), geranylgeranyltransferase (33), and indi-
rectly with rapsyn (1). MuSK in association with the tyrosine
phosphatase SHP-2 in cultured myotubes was recently found
(R. Willmann, A. Camilleri, C. Fuhrer, unpublished observa-
tions). MAGI-1c is another protein that, at least in a torpedo
electric organ, associates with MuSK (47). The plethora of
MuSK-associated partners opens the possibility that agrin
binding to its receptor complex may rapidly trigger conforma-
tional changes in such associated proteins in combination with
kinase activation (Abl, SFKs) and/or phosphatase inactivation
(possibly SHP-2). Such mechanisms could hold MuSK in an
activated state independently of bound agrin and increase its
phosphorylation status. In agreement with this, ectopic over-
expression in muscle of constitutively active MuSK induces
AChR aggregation in the absence of agrin (30), showing that
MuSK can cause AChR clustering independently of agrin.
Our mechanism of MuSK activation proposes that when a
critical level of MuSK phosphorylation is reached, the maximal
clustering program is initiated. This mechanism may explain
two prominent aspects of AChR clustering at the NMJ. The
first is that myotubes contain several inhibitory mechanisms
that counteract clustering. Rapsyn, for example, does not form
clusters ectopically in mammalian muscle in vivo (35), and its
clustering is marginal in cultured myotubes not treated with
agrin, although rapsyn associates with AChRs in such cells
(41). In contrast, rapsyn alone efficiently self aggregates in
heterologous cells (12, 43). This implies that muscle-specific
inhibition prevents rapsyn from clustering unless agrin and a
synaptic environment are present. Another inhibitory mecha-
nism is tyrosine phosphatases that dephosphorylate the AChR
constitutively, as shown by a strong increase in receptor phos-
phorylation by pervanadate treatment in the absence of agrin
(40, 54). Thus, the tyrosine kinase cascade downstream of
MuSK is continuously counteracted by phosphatases which
must be overcome by kinase activation through agrin (54). Our
data imply that agrin overrides the inhibition associated with
rapsyn and phosphatases with a threshold-like mechanism:
when a critical level of MuSK phosphorylation is reached after
a single agrin pulse, inhibition is overcome, allowing clustering
to proceed autonomously and maximally. Besides recruitment
of downstream signaling partners to critical phosphotyrosines
in MuSK (see above), this may involve MuSK-mediated phos-
phorylation of downstream effectors that may operate auton-
omously beyond a certain level of their activation.
The second feature of NMJ development for which our
mechanism of MuSK activation may be important is the highly
regulated spatial AChR distribution in which high receptor
densities lie only microns apart from regions that contain very
few AChRs (24, 45). Signaling that underlies clustering must
therefore operate with a high spatial resolution. This could be
achieved by a mechanism in which agrin stimulation, when
producing a critical level of MuSK phosphorylation, triggers
maximal clustering autonomously. In regions where stimula-
tion is beyond this level, clustering would occur maximally,
while in regions where this level is not reached, the inhibitory
mechanisms detailed above would strongly reduce cluster for-
mation. The postsynaptic membrane may thereby be sculpted
in vivo, and the effector proteins in such a cascade will be
interesting topics of future research.
A rapidly triggered autonomous agrin pathway—a mecha-
nism in the CNS? In contrast to neurotransmitter receptors at
synapses in the central nervous system (CNS), AChR cluster-
ing at the NMJ occurs much more slowly. CNS receptors can
cluster and synapses can form within 1 to 2 h (5). Increasing
evidence suggests that agrin is found concentrated at interneu-
ronal synapses (28, 32) and may also play a role in synapse
formation, including receptor clustering, between neurons (4,
9, 18), in addition to its importance at the immunological
synapse (31). So how could agrin act in the CNS if it takes so
long to cluster muscle AChRs? The features revealed here
show that agrin activates its receptor and initiates the AChR
clustering pathway extremely rapidly. Thus, it is not the agrin
itself that is slow in activating the agrin receptor; rather, the
downstream signaling pathway in muscle is slow in ultimately
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leading to AChR clusters. If coupled to a more rapid down-
stream pathway in neurons, a CNS agrin receptor, for which
there are indications (28), would therefore be in a position to
rapidly form a synapse. The rapid action of agrin inferred from
our study could thereby rapidly lead to CNS receptor cluster-
ing, rapid enough for a CNS synapse to form.
Studies on the NMJ have shown that AChR clustering is
under complex control, involving positive as well as negative
regulation. Laminin converges with agrin signaling at the level
of rapsyn (36), while neurotrophins (BDNF and NT-4) and
neuregulin can inhibit AChR clustering (53, 57). Neurons may,
in an analogous way, have multiple pathways that affect neu-
rotransmitter receptor clustering. While an autonomous path-
way rapidly triggered by agrin may be one mechanism for
induction of CNS synapses, CNS synapse formation may be
influenced by a more complex network of positive and negative
signals that reflects the dynamic nature of synapses in the
brain.
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